This is a prospective study to establish the analytical specificity of Bladder EpiCheck test in urine samples from healthy population and urology patients without prior history or evidence of bladder cancer.
Study Type
OBSERVATIONAL
Enrollment
168
Bladder EpiCheckTM (EpiCheck) is a urine test for monitoring of recurrence of NMIBC based on analysis of 15 informative DNA methylation biomarkers.
Urology San Antonio
San Antonio, Texas, United States
Specificity
The primary endpoint of the study is the specificity of the Bladder EpiCheck Test in healthy population.
Time frame: Day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.